Patent Assignment
Reel/Frame 033417/0304
Release of Security Interest
Recorded: 2014-07-25
Pages: 5
Assignor
GENERAL ELECTRIC CAPITAL CORPORATION
Executed: 2014-07-18
Assignee
TRIMEL BIOPHARMA SRL
THE GROVE, 21 PINE STREET, BELLEVILLE, ST. MICHAEL, 11113, BARBADOS
Covered Properties
(19)
Intranasal Methods of Treating Women for Anorgasmia with 0.6% and 0.72% Testosterone Gels
Intranasal 0.45% and 0.48% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
13/471,449 →
Publication:
US 2013/0040922
Intranasal 0.15% and 0.24% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
13/471,450 →
Publication:
US 2013/0045958
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
13/471,452 →
Publication:
US 2013/0040923
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/486,251 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/486,252 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/486,254 →
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/486,266 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/513,495 →
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/513,497 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/513,499 →
Intranasal 0.15% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application:
61/518,903 →
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application:
61/518,913 →
Intranasal 0.45% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application:
61/518,916 →
Intranasal 0.6% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application:
61/518,921 →
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/598,329 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/598,333 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/598,335 →
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
61/598,336 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0843 →
Assignment of Assignor's Interest
Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0574 →
Assignment of Assignor's Interest
Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0121 →
Assignment of Assignor's Interest
Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0386 →
Assignment of Assignor's Interest
Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0484 →
Assignment of Assignor's Interest
Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0265 →
Assignment of Assignor's Interest
Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0907 →
Assignment of Assignor's Interest
Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0674 →
Security Agreement
Jul 23, 2012
From: TRIMEL BIOPHARMA SRL
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028613/0855 →
Security Interest
Jul 25, 2014
From: TRIMEL BIOPHARMA SRL
To: MIDCAP FUNDING V, LLC
Reel/Frame 033416/0897 →
Assignment of Assignor's Interest
Oct 9, 2015
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036827/0897 →
Release of Security Interest
Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Assignment of Assignor's Interest
Dec 19, 2019
From: TRIMEL BIOPHARMA SRL
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 051337/0832 →